|
1
|
Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors.
|
Science
|
2002
|
7.70
|
|
2
|
RIP3 mediates the embryonic lethality of caspase-8-deficient mice.
|
Nature
|
2011
|
6.03
|
|
3
|
Virus inhibition of RIP3-dependent necrosis.
|
Cell Host Microbe
|
2010
|
3.70
|
|
4
|
DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA.
|
Cell Host Microbe
|
2012
|
3.23
|
|
5
|
Activation of innate immunity is required for efficient nuclear reprogramming.
|
Cell
|
2012
|
2.99
|
|
6
|
NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules.
|
J Exp Med
|
2003
|
2.75
|
|
7
|
Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL.
|
J Biol Chem
|
2013
|
2.24
|
|
8
|
Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis.
|
J Virol
|
2003
|
2.03
|
|
9
|
Pathogen subversion of cell-intrinsic innate immunity.
|
Nat Immunol
|
2007
|
1.97
|
|
10
|
Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response.
|
J Virol
|
2004
|
1.94
|
|
11
|
Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1.
|
J Biol Chem
|
2008
|
1.78
|
|
12
|
Differential function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate and rodent cytomegaloviruses.
|
Virology
|
2003
|
1.75
|
|
13
|
Cutting edge: FAS (CD95) mediates noncanonical IL-1β and IL-18 maturation via caspase-8 in an RIP3-independent manner.
|
J Immunol
|
2012
|
1.71
|
|
14
|
Receptor-interacting protein homotypic interaction motif-dependent control of NF-kappa B activation via the DNA-dependent activator of IFN regulatory factors.
|
J Immunol
|
2008
|
1.66
|
|
15
|
Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis.
|
Circulation
|
2004
|
1.62
|
|
16
|
T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
|
Circulation
|
2006
|
1.46
|
|
17
|
Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus.
|
J Virol
|
2003
|
1.44
|
|
18
|
Mitochondrial cell death suppressors carried by human and murine cytomegalovirus confer resistance to proteasome inhibitor-induced apoptosis.
|
J Virol
|
2005
|
1.39
|
|
19
|
Betaherpesvirus-conserved cytomegalovirus tegument protein ppUL32 (pp150) controls cytoplasmic events during virion maturation.
|
J Virol
|
2006
|
1.30
|
|
20
|
Viral and cell cycle-regulated kinases in cytomegalovirus-induced pseudomitosis and replication.
|
PLoS Pathog
|
2007
|
1.29
|
|
21
|
Proapoptotic chemotherapeutic drugs induce noncanonical processing and release of IL-1β via caspase-8 in dendritic cells.
|
J Immunol
|
2013
|
1.28
|
|
22
|
Viral modulation of programmed necrosis.
|
Curr Opin Virol
|
2013
|
1.20
|
|
23
|
Global analysis of host cell gene expression late during cytomegalovirus infection reveals extensive dysregulation of cell cycle gene expression and induction of Pseudomitosis independent of US28 function.
|
J Virol
|
2004
|
1.19
|
|
24
|
Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation.
|
Blood
|
2003
|
1.19
|
|
25
|
Predicting coding potential from genome sequence: application to betaherpesviruses infecting rats and mice.
|
J Virol
|
2005
|
1.16
|
|
26
|
Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination.
|
Blood
|
2005
|
1.15
|
|
27
|
Control of cytoplasmic maturation events by cytomegalovirus tegument protein pp150.
|
J Virol
|
2008
|
1.15
|
|
28
|
Viral and host control of cytomegalovirus maturation.
|
Trends Microbiol
|
2012
|
1.15
|
|
29
|
Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection.
|
Transplantation
|
2006
|
1.11
|
|
30
|
RNA analysis by biosynthetic tagging using 4-thiouracil and uracil phosphoribosyltransferase.
|
Methods Mol Biol
|
2008
|
1.09
|
|
31
|
Human cytomegalovirus exploits ESCRT machinery in the process of virion maturation.
|
J Virol
|
2009
|
1.09
|
|
32
|
Updated guidelines on the management of cytomegalovirus reactivation in patients with chronic lymphocytic leukemia treated with alemtuzumab.
|
Clin Lymphoma Myeloma
|
2006
|
1.09
|
|
33
|
Cytomegalovirus impairs antiviral CD8+ T cell immunity by recruiting inflammatory monocytes.
|
Immunity
|
2012
|
1.07
|
|
34
|
Cytomegalovirus pUL96 is critical for the stability of pp150-associated nucleocapsids.
|
J Virol
|
2011
|
1.05
|
|
35
|
HtrA2/Omi terminates cytomegalovirus infection and is controlled by the viral mitochondrial inhibitor of apoptosis (vMIA).
|
PLoS Pathog
|
2008
|
1.00
|
|
36
|
The carboxyl-terminal region of human cytomegalovirus IE1491aa contains an acidic domain that plays a regulatory role and a chromatin-tethering domain that is dispensable during viral replication.
|
J Virol
|
2005
|
0.99
|
|
37
|
The need and challenges for development of an Epstein-Barr virus vaccine.
|
Vaccine
|
2013
|
0.98
|
|
38
|
Impact of human cytomegalovirus latent infection on myeloid progenitor cell gene expression.
|
J Virol
|
2004
|
0.97
|
|
39
|
Expression of human CXCR2 in murine neutrophils as a model for assessing cytomegalovirus chemokine vCXCL-1 function in vivo.
|
J Interferon Cytokine Res
|
2004
|
0.96
|
|
40
|
Cytomegalovirus-induced embryopathology: mouse submandibular salivary gland epithelial-mesenchymal ontogeny as a model.
|
BMC Dev Biol
|
2006
|
0.95
|
|
41
|
Human cytomegalovirus alters localization of MHC class II and dendrite morphology in mature Langerhans cells.
|
J Immunol
|
2006
|
0.94
|
|
42
|
Frequent occult infection with Cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxis.
|
J Clin Microbiol
|
2007
|
0.92
|
|
43
|
Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levels.
|
Mol Immunol
|
2011
|
0.92
|
|
44
|
Cyclosporine inhibits mouse cytomegalovirus infection via a cyclophilin-dependent pathway specifically in neural stem/progenitor cells.
|
J Virol
|
2007
|
0.92
|
|
45
|
Transcription of true late (γ2) cytomegalovirus genes requires UL92 function that is conserved among beta- and gammaherpesviruses.
|
J Virol
|
2013
|
0.92
|
|
46
|
Cytomegalovirus UL91 is essential for transcription of viral true late (γ2) genes.
|
J Virol
|
2013
|
0.91
|
|
47
|
The spleen plays a central role in primary humoral alloimmunization to transfused mHEL red blood cells.
|
Transfusion
|
2009
|
0.91
|
|
48
|
Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors.
|
Blood
|
2002
|
0.90
|
|
49
|
Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patients.
|
PLoS One
|
2009
|
0.90
|
|
50
|
Contribution of GADD45 family members to cell death suppression by cellular Bcl-xL and cytomegalovirus vMIA.
|
J Virol
|
2005
|
0.89
|
|
51
|
Identification and classification of acute cardiac rejection by intragraft transcriptional profiling.
|
Circulation
|
2011
|
0.89
|
|
52
|
Changes in coronary arterial dimensions early after cardiac transplantation.
|
Transplantation
|
2007
|
0.89
|
|
53
|
Manipulation of apoptosis and necroptosis signaling by herpesviruses.
|
Med Microbiol Immunol
|
2015
|
0.88
|
|
54
|
Antiviral T cell response triggers cytomegalovirus hepatitis in mice.
|
J Virol
|
2012
|
0.82
|
|
55
|
Repression of human cytomegalovirus major immediate early gene expression by the cellular transcription factor CCAAT displacement protein.
|
Virology
|
2008
|
0.82
|
|
56
|
Multiplicity-dependent activation of a serine protease-dependent cytomegalovirus-associated programmed cell death pathway.
|
Virology
|
2012
|
0.80
|
|
57
|
Inhibition of 2',5'-oligoadenylate synthetase expression and function by the human cytomegalovirus ORF94 gene product.
|
J Virol
|
2011
|
0.80
|
|
58
|
Highly acidic C-terminal region of cytomegalovirus pUL96 determines its functions during virus maturation independently of a direct pp150 interaction.
|
J Virol
|
2014
|
0.79
|
|
59
|
Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: modulation by sirolimus.
|
Transplantation
|
2008
|
0.79
|
|
60
|
Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation.
|
J Heart Lung Transplant
|
2007
|
0.78
|
|
61
|
Gene products of the embedded m41/m41.1 locus of murine cytomegalovirus differentially influence replication and pathogenesis.
|
Virology
|
2013
|
0.77
|
|
62
|
Comparison of polymerase chain reaction of polymorphonuclear leukocytes and plasma identifies patients who control cytomegalovirus infection after hematopoietic cell transplantation.
|
Clin Infect Dis
|
2008
|
0.75
|
|
63
|
Cytomegalovirus and heart transplant atherosclerosis: a likely guilt hidden by weak proofs.
|
Transplantation
|
2004
|
0.75
|
|
64
|
Mechanisms modulating immune clearance during human cytomegalovirus latency.
|
Proc Natl Acad Sci U S A
|
2012
|
0.75
|
|
65
|
[Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic syndrome].
|
G Ital Cardiol (Rome)
|
2007
|
0.75
|
|
66
|
Natural antisense transcripts of UL123 packaged in human cytomegalovirus virions.
|
Arch Virol
|
2013
|
0.75
|